BSEM

BioStem Technologies, Inc. · Healthcare · Market cap $13.6M

Insiders sold $14K net in the last 90 days ·1 seller, 0 buyers· latest Form 4 filed Nov 19, 2026

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$14K

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Latest filing

Nov 19, 2026

Matuszewski Jason

BioStem Technologies, Inc. (BSEM) has 19 SEC Form 4 filings (21 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Nov 19, 2026.

Inside the rolling window, 1 insider at BioStem Technologies, Inc. reported no open-market purchases and 1 open-market sale totaling $14K. The most recent open-market filing is a sale of 14,300 shares by Chief Executive Officer Matuszewski Jason, dated Nov 17, 2026, worth $14K.

  • Industry:Biotechnology
  • CEO:Jason Matuszewski
  • Employees:73
  • HQ:Fort Lauderdale, FL, US
  • IPO:2015-03-17
Source
Matuszewski JasonFirst filing
Sale$14KNov 19SEC ↗
Showing 1–1 of 1
1 / 1

Earnings: last 7 quarters

EstimatedActual

Frequently asked questions

How many SEC Form 4 insider filings does BSEM have?

BioStem Technologies, Inc. (BSEM) has 19 SEC Form 4 filings (21 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Nov 19, 2026.

When was the most recent SEC Form 4 filing for BSEM?

The most recent Form 4 filing for BSEM on Tracefour is dated Nov 19, 2026.

What is the net insider flow at BSEM over the last 6 months?

Over the trailing 180 days, insiders at BSEM have net sold $14K based on SEC Form 4 disclosures.

What is the total insider buy and sell value at BSEM in the current window?

Inside the rolling window, insiders at BSEM bought $0 and sold $14K based on SEC Form 4 filings.

Can I get alerts for BSEM insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at BioStem Technologies, Inc. (BSEM). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

BioStem Technologies, Inc. is in the Healthcare sector.